Astera Labs, Inc.
ALAB
$63.55
-$3.37-5.04%
| Weiss Ratings | ALAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | ALAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | ALAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Price History | ALAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -15.93% | |||
| 30-Day Total Return | -44.89% | |||
| 60-Day Total Return | -47.82% | |||
| 90-Day Total Return | -12.37% | |||
| Year to Date Total Return | -52.70% | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -54.60% | |||
| 52-Week Low % Change | 84.79% | |||
| Price | ALAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $147.39 | |||
| 52-Week Low Price | $36.22 | |||
| 52-Week Low Price (Date) | Aug 07, 2024 | |||
| 52-Week High Price (Date) | Jan 06, 2025 | |||
| Valuation | ALAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 10.85B | |||
| Enterprise Value | 9.94B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -1.73 | |||
| Earnings Per Share Growth | 131.34% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 29.98 | |||
| Price/Book (Q) | 11.24 | |||
| Enterprise Value/Revenue (TTM) | 25.08 | |||
| Price | $63.68 | |||
| Enterprise Value/EBITDA (TTM) | -88.03 | |||
| Enterprise Value/EBIT | -85.64 | |||
| Market Cap Category | Large Cap | |||
| Dividends and Shares | ALAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 177.56M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ALAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 408 766 3806 | |||
| Address | 2901 Tasman Drive Santa Clara, CA 95054 | |||
| Website | www.asteralabs.com | |||
| Country | United States | |||
| Year Founded | 2017 | |||
| Profitability | ALAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -29.28% | |||
| Profit Margin | -21.05% | |||
| Management Effectiveness | ALAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -11.60% | |||
| Return on Equity | -- | |||
| Income Statement | ALAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 396.29M | |||
| Total Revenue (TTM) | 396.29M | |||
| Revenue Per Share | $2.23 | |||
| Gross Profit (TTM) | 302.70M | |||
| EBITDA (TTM) | -112.91M | |||
| EBIT (TTM) | -116.07M | |||
| Net Income (TTM) | -83.42M | |||
| Net Income Avl. to Common (TTM) | -83.42M | |||
| Total Revenue Growth (Q YOY) | 179.32% | |||
| Earnings Growth (Q YOY) | 72.52% | |||
| EPS Diluted (TTM) | -1.73 | |||
| EPS Diluted Growth (Q YOY) | -62.45% | |||
| Balance Sheet | ALAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 914.30M | |||
| Cash Per Share (Q) | $5.15 | |||
| Total Current Assets (Q) | 1.01B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 964.80M | |||
| Current Ratio (Q) | 11.705 | |||
| Book Value Per Share (Q) | $5.95 | |||
| Total Assets (Q) | 1.05B | |||
| Total Current Liabilities (Q) | 86.54M | |||
| Total Debt (Q) | 3.07M | |||
| Total Liabilities (Q) | 89.71M | |||
| Total Common Equity (Q) | 964.80M | |||
| Cash Flow | ALAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -757.57M | |||
| Cash from Financing (TTM) | 655.84M | |||
| Net Change in Cash (TTM) | 34.95M | |||
| Levered Free Cash Flow (TTM) | 84.23M | |||
| Cash from Operations (TTM) | 136.68M | |||
